PILLER Véronique

email : veronique.piller@cnrs-orleans.fr

Phone :+33 2.38.25.76.46 ou 78.05

Office A211

Researcher within the thematic group “Synthetic protein and bioorthogonal chemistry

 



18 documents

Article dans une revue

  • David Montoir, Mehdi Amoura, Zine El Abidine Ababsa, T. Vishwanatha, Expédite Yen-Pon, et al.. Synthesis of aryl-thioglycopeptides through chemoselective Pd-mediated conjugation. Chemical Science , The Royal Society of Chemistry, 2018, 9 (46), pp.8753-8759. ⟨hal-01966170⟩
  • Aline Mongis, Friedrich Piller, Véronique Piller. Coupling of Immunostimulants to Live Cells through Metabolic Glycoengineering and Bioorthogonal Click Chemistry. Bioconjugate Chemistry, American Chemical Society, 2017, 28 (4), pp.1151 - 1165. ⟨10.1021/acs.bioconjchem.7b00042⟩. ⟨hal-01618670⟩
  • Mathieu Galibert, Véronique Piller, Friedrich Piller, Vincent Aucagne, Agnès F. Delmas. Combining triazole ligation and enzymatic glycosylation on solid phase simplifies the synthesis of very long glycoprotein analogues. Chemical Science , The Royal Society of Chemistry, 2015, 6 (6), pp.3617-3623. ⟨10.1039/C5SC00773A⟩. ⟨hal-01178852⟩
  • Kelly N. Chuh, Balyn W. Zaro, Friedrich Piller, Véronique Piller, Matthew R. Pratt. Changes in Metabolic Chemical Reporter Structure Yield a Selective Probe of O-GlcNAc Modification. Journal of the American Chemical Society, American Chemical Society, 2014, 136 (35), pp.12283-12295. ⟨10.1021/ja504063c⟩. ⟨hal-01178483⟩
  • Alicja Solatycka, Tomasz Owczarek, Friedrich Piller, Véronique Piller, Bartosz Pula, et al.. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase. Glycobiology, Oxford University Press (OUP), 2012, 22 (8), pp.1042-54. ⟨10.1093/glycob/cws075⟩. ⟨hal-00726281⟩
  • Sabrina Pouilly, Véronique Piller, Friedrich Piller. Metabolic glycoengineering through the mammalian GalNAc salvage pathway.. FEBS Journal, Wiley, 2012, 279 (4), pp.586-98. ⟨10.1111/j.1742-4658.2011.08448.x⟩. ⟨hal-00726255⟩
  • Sabrina Pouilly, Vanessa Bourgeaux, Friedrich Piller, Véronique Piller. Evaluation of analogues of GalNAc as substrates for enzymes of the mammalian GalNAc salvage pathway.. ACS Chemical Biology, American Chemical Society, 2012, 7 (4), pp.753-60. ⟨10.1021/cb200511t⟩. ⟨hal-00726252⟩
  • Vanessa Bourgeaux, Martine Cadène, Friedrich Piller, Véronique Piller. Efficient Enzymatic Glycosylation of Peptides and Oligosaccharides from GalNAc and UTP. ChemBioChem, Wiley-VCH Verlag, 2007, 8 (1), pp.37-40. ⟨10.1002/cbic.200600369⟩. ⟨hal-00158348⟩
  • Vanessa Bourgeaux, Martine Cadene, Friedrich Piller, Véronique Piller. Efficient enzymatic glycosylation of peptides and oligosaccharides from GalNAc and UTP. ChemBioChem, Wiley-VCH Verlag, 2007, 8 (1), pp.37-40. ⟨hal-00282379⟩
  • Teresa Freire, Richard Lo-Man, Friedrich Piller, Véronique Piller, Claude Leclerc, et al.. Enzymatic large-scale synthesis of MUC6-Tn glycoconjugates for antitumor vaccination.. Glycobiology, Oxford University Press (OUP), 2006, 16 (5), pp.390-401. ⟨10.1093/glycob/cwj082⟩. ⟨pasteur-00166623⟩
  • Gaëlle-Anne Cremer, Nicole Bureaud, Véronique Piller, Horst Kunz, Friedrich Piller, et al.. Synthesis and biological evaluation of a multiantigenic Tn/TF-containing glycopeptide mimic of the tumor-related MUC1 glycoprotein. ChemMedChem, Wiley-VCH Verlag, 2006, 1 (9), pp.965-968. ⟨10.1002/cmdc.200600104⟩. ⟨hal-00168620⟩
  • E. Mennesson, P. Erbacher, V. Piller, C. Kieda, P. Midoux, et al.. Transfection efficiency and uptake process of polyplexes in human lung endothetial cells: a comparative study in non-polarized and polarized cells. The Journal of Gene Medicine, Wiley, 2005, 7, pp.729-738. ⟨hal-00088642⟩
  • V. Bourgeaux, F. Piller, V. Piller. Two-step enzymatic synthesis of UDP-N-acetylgalactosamine. Bioorganic and Medicinal Chemistry, Elsevier, 2005, 15, pp.5459-5462. ⟨hal-00088511⟩
  • I. Martinez-Duncker, T. DuprÉ, V. Piller, F. Piller, J.J. Candelier, et al.. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood, American Society of Hematology, 2005, 105, pp.2671-2676. ⟨hal-00088624⟩
  • S. Duclos, P. da Silva, F. Vovelle, F. Piller, V. Piller. Characterization of the UDP-N- acetylgalactosamine binding domain of bovine polypeptide α N-acetylgalactosaminyltranferase T1. Protein Engineering, Design and Selection, Oxford University Press (OUP), 2004, 17 (8), pp.635-646. ⟨10.1093/protein/gzh075⟩. ⟨hal-00112977⟩
  • G.A. Cremer, N. Bureaud, D. Lelièvre, V. Piller, F. Piller, et al.. Synthesis of branched oxime-linked peptide mimetics of the MUC1 containing a universal T-helper epitope. Chemistry - A European Journal, Wiley-VCH Verlag, 2004, 10 (24), pp.6353-6360. ⟨10.1002/chem.200400780⟩. ⟨hal-00112972⟩
  • M. Dalziel, F. Dall'Olio, A. Mungul, V. Piller, F. Piller. Ras oncogene induces β-galactoside α2,6-sialytransferase (ST6Gal I) via a RalGEF-mediated signal to its housekeeping promoter. European Journal of Biochemistry, Wiley, 2004, 271 (18), pp.3623-3634. ⟨10.1111/j.1432-1033.2004.04284.x⟩. ⟨hal-00112974⟩
  • V. Carrière, V. Piller, Alain Legrand, M. Monsigny, A.C. Roche. The sugar binding activity of MR60, a mannose-specific shuttling lectin, requires a dimeric state. Glycobiology, Oxford University Press (OUP), 1999, 9 (10), pp.995-1002. ⟨10.1093/glycob/9.10.995⟩. ⟨hal-02138032⟩